✦ LIBER ✦

Hepatitis G virus infection in drug users in liverpool

✍ Scribed by N. Kennedy; C.Y.W. Tong; N.J. Beeching; K. Lamden; H. Williams; K.J. Mutton; C.A. Hart

Book ID: 108407650
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 687 KB
Volume: 37
Category: Article
ISSN: 0163-4453
DOI: 10.1016/s0163-4453(98)80168-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis C virus infection in intraveno

Hepatitis C virus infection in intravenous drug users

✍ J. Harder; E. Walter; B. Riecken; C. Ihling; T. M. Bauer 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Treatment of hepatitis C virus infection

Treatment of hepatitis C virus infection in intravenous drug users

✍ Matthew L Cowan; James D Maxwell 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 Dutch ⚖ 126 KB

Hepatitis C viral infection in drug user

Hepatitis C viral infection in drug users

✍ Diana L. Sylvestre 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 755 KB

HTLV-II infection in a Liverpool intrave

HTLV-II infection in a Liverpool intravenous drug user

✍ C.M. Parry; A.D. Harries; N.J. Beeching; I.M. Shaw; K.J. Mutton; L. McAlpine; J. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Hepatitis C virus infection among noninj

Hepatitis C virus infection among noninjecting drug users in New York City

✍ Beryl A. Koblin; Stephanie H. Factor; Yingfeng Wu; David Vlahov 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 1 views

## Abstract The prevalence of hepatitis C virus (HCV) infection among noninjecting drug users has been reported to be higher than in the general population, but the reasons for this observation remain unclear. Noninjecting drug users aged 15–40 years and who used drugs for no longer than 10 years w

Molecular analysis of hepatitis C virus

Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users

✍ Massimo Ciccozzi; Gianni Zehender; Valeria Cento; Alessandra Lo Presti; Pavel Te 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 1 views

## Abstract Intravenous drug users constitute a group at risk for hepatitis C virus (HCV) infection. Today, no data are available on the molecular epidemiology of HCV in Bulgaria despite the fact that in recent years the incidence of acute hepatitis C infection among Bulgarian intravenous drug user